BRIEF-Roche, Lilly drugs chosen for trial to prevent early-onset Alzheimer's

Oct 10 (Reuters) - washington University in St. Louis:

* Says Roche drug gantenerumab, Eli Lilly's solanezumab chosen for

alzheimer's prevention trial -- Washington university

* Lilly beta secretase inhibitor also selected for potential inclusion

in global trial - Washington university

* Trial expected to begin early 2013 to test three drugs; each target

alzheimer's in different way -- Washington university

* Trial to be conducted at Washington university by dominantly inherited

alzheimer's network trials unit (dian tu) -- Washington university

* Trial to involve 160 people with inherited gene mutations that typically lead

to alzheimer's at young age -- Washington university

((New York Equities Desk; tel: +1 646 223 6000))

((For more news about ROCHE-LILLY click here: ))